Connect with us

Electronics

Chinese Quantum Physicists Develop Ultra-Powerful, Anti-Stealth Military Radar

Published

on

Anti-Stealth

A top Chinese military technology company announced the development and preliminary testing of a new form of radar able to detect stealth planes 100km away, South China Morning Post recently reported.

// -- Discuss and ask questions in our community on Workplace. Don't have an account? Send Jonas Borchgrevink an email -- //

The state-owned China Electronics Technology Group Corporation (CETC), one of the top Chinese military industry groups controlled directly by the central government, develops and deploys key hardware components, software, and information systems for military and civilian applications. Since March 2016, the CETC is also tasked with technical support to counter-terrorism.

According to a statement published on the CETC website, the new radar developed by engineers at CETC’s Intelligent Perception Technology Laboratory is China’s first “single-photon quantum radar system” and uses entangled photons to identify objects invisible to conventional radar systems, which has important military applications.

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

Quantum entanglement, the “spooky action at a distance” that baffled Einstein but was later recognized as a key feature of quantum systems, results in correlations between remote particles that, in some cases, can be exploited for remote sensing. Given the military applications of the projects, it’s not surprising that the CETC scientists have not disclosed detailed information. However, quantum radars studies have been published in the open scientific literature. See American Physical Society’s “Focus: Quantum Mechanics Could Improve Radar” for an overview.

Beyond Science Fiction

Military radarThe popular online magazine Daily Galaxy described the Chinese quantum physics breakthrough as “Beyond Science Fiction.” DARPA has reportedly funded similar research and military suppliers such as Lockheed Martin are also developing quantum radar systems for combat purposes, according to media reports, but the progress of those military projects remains unknown.

“The effective range reported by the international research community falls far below 100km,” said Prof. Ma Xiaosong, a Nanjing University physicist, adding that he had “not seen anything like this in an open report.” Another Chinese military radar researcher hinted that the actual range of the new radar could be even greater than the 100km announced by CETC.

Besides the range, the key feature of the new radar is its ability to detect stealth planes. Other possible applications include small, highly mobile and sensitive radar systems able to survive combat and evade enemy countermeasures.

A Completely New Area of Research

According to CETC, the field testing of the new radar opens up a “completely new area of research.” Lockheed Martin was granted a patent in 2008 for a “Radar systems and methods using entangled quantum particles” able to “visualize useful target details through background and/or camouflaging clutter, through plasma shrouds around hypersonic air vehicles, through the layers of concealment hiding underground facilities, IEDs, mines, and other threats.”

Popular Mechanics notes that, since the 2008 patent, Lockheed Martin has been “silent on the subject of quantum radars.”

Given what a technological leap such a system would be, it’s quite possible the research has gone ‘black’ – highly classified and subject to a high level of secrecy.

Another possibility is that research in the US might not have advanced much. Of course, the Chinese results could be over-hyped. Popular Mechanics warns that the fact that the quantum radar breakthrough has been first reported by state-owned media is suspicious, but that can be also interpreted as an indication of the interest of the Chinese government in next-generation quantum technologies.

SCMP notes that CETC collaborated with quantum scientists at the University of Science and Technology of China, where many quantum technology breakthroughs have been achieved, including the world’s longest quantum key distribution network for secured communication and the development of the world’s first quantum satellite recently covered by Hacked.

In fact, it appears that China is engaging in a government-supported, well-funded quantum technology development effort ranging from unbreakable encrypted communication networks to combat support operations. Next-generation quantum technologies with military applications may arrive sooner than we think: policy makers and military planners in the West should bear in mind that China is striving to achieve quantum supremacy.

Images from iStock and Wikimedia Commons.

Important: Never invest money you can't afford to lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here.



Feedback or Requests?

10 Comments

10 Comments

  1. Manju

    October 4, 2016 at 10:30 am

    Since I am unable to build stealth planes I’ll create a news that I developed a radar that could track stealth planes. Atleast that will make my adversaries with stealth think before attacking. That’s China in short for you.

  2. Top secret clearence

    October 5, 2016 at 3:46 am

    In August 15, 2016 China launch a quantum communication satellite using Pan Jian Wei study of quantum physics. The satellite is called Micius( a 5 BC philosopher that opposes offensive weapons) China layed a quantum communication fiber optic underground line from Beijing to Shanghai. I think China has quantum radar because it is a short development from quantum communication to quantum radar. The stealth F-22 moved from Japan to Guam hopefully out of quantum radar range. China spent 10 billion dollars for quantum physics . The US spent 200 million per year for quantum physic and we still do not have it. China has a 4 trillion dollars surplus and owns 1 trillion dollars or more in US treasury bonds.We could use some of it to build our infrastructures.The US has a 14 trillion dollars debt because the rich do not pay taxes (see Donald Trump taxes).The stealth J-20 and the stealth J-31 was shown in 2011 to US Defense Secretary Gates.On September 18, 2015 a airplane flew at mach 6 speed and landed.I think the stealth airplane used two Wang Zhengou turbo scram jet engine (see Popular Science article about him and turbo-scram jet engine) and Shou-En Zhu grapheme air frame similar to C919 air frame.China is developing these and lot more weapons to safe guard their trade which is threaten by the Pivot to Asia in the Malacca straits and the South China Seas.China has 1,000 mobile WU-14 supersonic missiles( DF-41 with MIVR) hidden in 3,000 miles of nuclear resistant tunnels with multiple exit built for possible attack by the former Soviet Union.There were 10 supersonic test of the DF-41 in 2015.On September 3,2015 16 DF-41 and 16 DF-31A was shown in the victory parade.The US Congress Recently authorized 170 million dollars for supersonic study.It is better to have China invest and build our infrastructures.I do not think China will attack the structures and Chinese people that might build them.

    • sky

      October 5, 2016 at 9:04 am

      All that you have mentioned the U.S already have it and China is trying to catch up. The J 20 and J 31 are Chinese copies of the F 35 and F22. China had to hack U.S. computers to have an idea on how do it. Another drawback is China cannot design and produce jet engines yet. China is 50 years behind the U.S. in technology and copying and imitating won’t do her much good.

      • Knowles222

        October 5, 2016 at 1:16 pm

        They can design and produce jet engines, they just haven’t achieve the same power output as jet engines the West and Russia can produce.

        An imitating and copying can drastically speed up a country development, it was by copying the British technology that leak out that many countries were able to undergo their industrial revolutions.

        But that also doesn’t mean they haven’t got a team of people who have a knack for working with and understanding of Quantum physics and are advancing the field faster than their Western rivals.

      • Top secret clearence

        October 5, 2016 at 2:31 pm

        On September !8,2015, an airplane flew several hours at mach 6 speed and landed.I think it used two Wang Zhengou turbo-scram jet engines(see Popular Science article about him and turbo-scram jet engine) and Shou-En Zhu low cost grapheme air frame like C919 air frame.China has spent 12 billion dollars to developed the WS-10A,WS-15 and turbo-scram jet engine.China high speed rail was a copy of three countries designed.Since then,China has built 12,000 miles of high speed tracks and a engine that goes 500 km per hour.I do not under estimate other people designed .(like the zero used in Pearl Harbor ) China has the largest and fastest computer in the world.Why don t we used the Quantum Communication to secure our banks? China has spent 10 billion dollars to developed Quantum Physics.The US has spent 200 million dollars a year and we still do not have it.China has 4 trillion dollars surplus and 1 trillion dollars or more in US treasury bonds.We could use the money to buy our infrastructure.The US is in debt for 14 trillion dollars because the rich(like Donald Trump) do not pay taxes.

      • Potthai Lang

        October 6, 2016 at 10:23 pm

        Yes…yes….whatever China has/developed is copied from American.

        Are Americans so stupid don’t even know how to safe guard what they invented ?

  3. Dux

    October 5, 2016 at 7:54 pm

    They probably do this frequently, but you’ll never hear about it as long as it remains undetected.

    • Potthai Lang

      October 6, 2016 at 10:33 pm

      If you are so useless unable to safe guard your property or invention, can you blame others ? What’s is wrong with copying ? God says we can’t copy ?
      There are many even don’t have the ability to copy even you give them your products. That’s why their gdp per capital is at par 4th world standard.

  4. Top secret clearence

    October 6, 2016 at 3:09 pm

    James Dale Davidson (advisor to 4 US presidents) said the day of reckoning is coming,we can not keep printing worthless money.China holds one trillion dollars or more in US treasury bonds.China has 4 trillion dollars surplus and spent 10 billion dollars for each project to defend it self.The US is in 14 trillion debt because the rich (like Donald Trump) do not pay taxes. The US is spending 200 million dollars or less for quantum physics and supersonic missiles which we do not have.We build obsolete 14 billion dollars aircraft carrier that could be sunk by a swarm of low cost supersonic YJ-18 attacking 15 feet above sea level and several WU-14 supersonic DF-21A or DF-26.Instead of economic collapsed and war,we should use the money China has to build up our infrastructure.

  5. Potthai Lang

    October 6, 2016 at 10:29 pm

    That’s Indian’s mindset. Their thinking is very colorful but always fail to deliver physical products. Just ignore him and let them enjoy gdp per capital of less than US$2000.

You must be logged in to post a comment Login

Leave a Reply

Biotech

Biotech Dominates July Penny Stock Picks

Published

on

July brings new opportunities to trade penny stocks, according to the Investopedia top 10 penny stocks to watch. Biotechnology stocks in particular are poised for a breakout. Biotechnology funds broke out of the long-term basing pattern in June, forcing rotational buying pressure, which bodes well for the low-priced sub-sector, with many penny stocks ready to hit multi-year highs.

// -- Discuss and ask questions in our community on Workplace. Don't have an account? Send Jonas Borchgrevink an email -- //

At the same time, the tech sector is getting sold with equal force in a profit-taking exercise that could deliver a period of under-performance for the sector’s lower-priced issues.

June’s biotechnology picks drew strong buying interest, led by ImmunoGen, Inc.’s 48% advance to a 52-week high. Small China stocks also posted strength, as China Commercial Credit, Inc. gained close to 35%. China Commercial Credit and June’s three biotech picks return to the July top penny stock list, joined by six new penny stocks.

1. ImmunoGen Inc. (IMGN)

Source: Investopedia

// -- Become a yearly Platinum Member and save 69 USD and get access to our secret group on Workplace. Click here to change your current membership -- //

ImmunoGen, a provider of antibody-drug conjugates (ADCs) for the treatment of cancer, jumped from number four in June to the top spot in July.

The stock posted a 12-year high at $20.25 in 2013 and sold off to $5.34 in December 2014. A recovery in 2015 stalled less than a point below the prior peak, creating a decline that continued into an 18-year low at $1.51 in November 2016.

Buyers took over in 2017, generating an uptick that reversed at the 2014 resistance approximately three weeks ago. In June, the stock broke out and made the top 10 list for the first time. It could end up in the $8.00 to $10.00 price zone.

ImmunoGen creates targeted cancer therapeutics using its proprietary ADC technology. The company’s candidate, mirvetuximab soravtansine, is in a Phase 3 trial for an ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease.

The technology is used in Roche’s Kadcyla, in three other clinical-stage ImmunoGen product candidates, and in programs in development by Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda.

2. China Commercial Credit, Inc. (CCCR)

Source: Investopedia

China Commercial Credit Inc. (CCCR), which provides business loans and loan guarantee services to small-to-medium enterprises (SMEs), farmers and individuals in China’s Jiangsu Province, jumped from number five in June to second place in July.

The company went public on the U.S. exchanges at $6.50 in August 2013.

The stock experienced a downtrend that bottomed out at 25 cents in February 2016 and began an upward trend that stalled at $3.20 in September. The stock hit a higher low in March 2017 before recovering, testing the 2016 high. A breakout should bring broad buying interest that could support a continued upside that could double the price by year’s end.

The company was founded in 2008 and provides business loans and loan guarantee services to small-to-medium enterprises, farmers and individuals in China’s Jiangsu Province.

3. CymaBay Therapeutics, Inc. (CBAY)

Source: Investopedia

CymaBay Therapeutics Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases, returns from the June list, where it ranked number 9. The stock rallied to an all-time high at $13.78 in February 2015, then suffered a steep downtrend that continued into the first quarter of 2016. The stock then dropped to an all-time low at 82 cents before bouncing to $3.04 in April, a yearly high, ahead of a pullback that continued into the November low at $1.15.

The stock broke above the 2016 high in February 2017, reaching a two-year high at $4.81.

Net loss for the 2017 first quarter was $5.4 million, or ($0.20) per diluted share, compared to $6.8 million, or ($0.29) per diluted share in the first quarter of 2016. Net loss in the 2017 first quarter was $1.4 million lower compared to the prior year period, primarily due to the recognition of collaboration revenue in 2017.

The rally has now reached a two-year high, attracting buying interest that could move into double digits.

4. Peiris Pharmaceuticals, Inc. (PIRS)

Source: Investopedia

Pieris Pharmaceuticals Inc., a, clinical-stage biotechnology company committed to providing solutions for oncology, respiratory disease and other therapeutic areas, moved from June’s 7th spot to July’s 4th spot. The stock launched on the OTC market in 2014, trading between $2.00 and $4.25 before falling to $1.26 in January 2016. It ground sideways through November, then tested the first-quarter low ahead of a January 2017 breakaway gap that has drawn steady buying interest. The rally gathered momentum in early May after announcing a partnership with AstraZeneca PLC and is currently testing the 2015 high, the all-time high.

The company’s product includes immuno-oncology multi-specifics tailored for the tumor microenvironment, an inhaled Anticalin protein to treat uncontrolled asthma as well as a half-life-optimized Anticalin protein to treat anemia. Anticalin proteins, proprietary to Pieris, are a class of therapeutics validated in the clinic and partnerships with pharmaceutical companies. Anticalin is a registered trademark of Pieris.

5. 22nd Century Group, Inc. (XXII)

Source: Investopedia

22nd Century Group, Inc. (XXII), a plant biotechnology company that is a provider of tobacco harm reduction and development of proprietary hemp/cannabis strains, broke out above multi-year resistance near $1.50 in 2013, rallying to a record high a few months later at $6.36. The stock then began a persistent decline through August 2015 before finding support at 56 cents, followed by a bounce to $1.75.

The stock has traded within those boundaries for 22-months, bouncing at support three times and reversing at resistance in equal measure. The price returned to that level a fourth time, improving odds for a breakout that could double the price in the year’s second half.

22nd Century Group is a plant biotechnology company focused on genetic engineering and plant breeding that allows the increase or decrease of the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants. The company’s main goal in tobacco is to reduce the harm caused by smoking. The main goal in cannabis is to develop proprietary hemp/cannabis strains for new medicines and agricultural crops.

The stock last month joined the Russell Microcap Index, when FTSE Russell reconstituted its U.S. and global equity indexes. Membership in the Russell Microcap Index means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

6. Corindus Vascular Robotics, Inc. (CVRS)

Source: Investopedia

Corindus Vascular Robotics, Inc. (CVRS), a developer of precision vascular robotics, returned to the national market in 2015 following a trading halt, topping out around $4.50 and starting a decline that continued to reach new lows in January 2017 when it bottomed at around 40 cents. Since that time, the price activity has been constructive, with high volume rally bursts moving the stock into 2016 resistance at $1.75. The bullish behavior has created a cup and handle basing pattern that points to an uptrend into the 2015 high following a breakout.

Revenue for the first quarter of 2017 was $0.8 million compared to $1.1 million for the same period in the prior year. The decrease is due mainly to the deferral of system revenue associated with a future obligation to upgrade multiple customer units from the company’s CorPath 200 System to the CorPath GRX System.

The company installed three new CorPath Systems in the first quarter of 2017, increasing its total installed base to 48 CorPath Systems.

Gross loss was $1.1 million for the 2017 first quarter, compared to a gross profit of $0.03 million for the 2016 first quarter. The cost of revenues for the first 2017 quarter continued to include the effect of under-utilization of production facilities and the cost of CorPath GRX System upgrades that installed pursuant to pre-existing contractual arrangements.

The company continues to expect the full year 2017 revenue to be in the range of $13.

7. RADA Electronic Industries, Ltd. (RADA)

Source: Investopedia

RADA Electronic Industries, Ltd. (RADA), a defense electronics system of advanced electronic systems for airborne and land applications, fell into a multi-decade decline after it joined the Nasdaq in the 1990s. The stock ground out a series of lower highs and lows through January 2016’s all-time 54-cent low.

The stock spent 16 months moving sideways in a narrow basing pattern before turning higher in May 2017 and rallying back to 2016 resistance at $1.78. The bullish activity completed a cup and handle breakout pattern that could point to a fast rally into the August 2015 gap between $3.70 and $2.50.

Revenues totaled $4.7 million in the 2017 first quarter, up 91% compared to revenues of $2.5 million in the first quarter of 2016.

Gross profit totaled $1.7 million in the first 2017 quarter of 2017, a gross margin of 35.7%, compared to gross profit of $6,000 (gross margin of 0.2%) in the 2016 first quarter.

Operating income was $0.4 million in the first 2017 quarter compared to an operating loss of $1 million in the 2016 first quarter.

Net income attributable to RADA’s shareholders in the 2017 first quarter was $0.4 million, $0.02 per share, versus a net loss of $1.8 million, or $0.23 per share, in the 2016 first quarter.

8. ChromaDex, Corp. (CDXC)

Source: Investopedia

ChromaDex, Corp. (CDXC), a provider of proprietary health, wellness and nutritional ingredients, that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition and pharmaceutical products, went public in April 2016 at $4.70. The stock rallied to an all-time high at $6.18 in May, then fell one month later to $2.46 in a single session, eventually posting a lower December low. It tested that support level in April 2017, then turned sharply higher, now testing 2017 resistance at $3.80. A breakout could point to a significant upside, taking the stock back to last year’s high.

For the first quarter of 2017, ChromaDex reported net sales of $4.4 million, a decrease of 39% compared to the same period of 2016, due mainly to decreased sales in its ingredients business segment, as a result of dropping its largest customer for fiscal year 2016. The ingredients segment created net sales of $2.1 million for Q1 2017, a decline of 55%, compared to the same 2016 period.

The net loss attributable to common stock holders for Q1 2017 was $1.9 million or ($0.05) per share versus a net income of $0.3 million or $0.01 per share for Q1 2016.

In May, the company announced the closing of the $16.4 million second tranche of the strategic investment of up to $25 million led by Hong Kong business leader Li Ka-shing.

Li Ka-shing has invested in many innovative companies in the last decade, including Facebook, Spotify, DeepMind, Siri, Impossible Foods and Modern Meadow. The new investment will support future ChromaDex developments in the global marketplace.

The $16.4 million second tranche follows an initial $3.5 million tranche that closed on April 27, 2017.

9. Safe Bulkers, Inc. (SB)

Source: Investopedia

Safe Bulkers, Inc. (SB), a player in the hot and cold dry bulk shipping sector, topped out at $11.48 in March 2014, then entered a downtrend reaching an all-time low at 30 cents in January 2016. A recovery wave in November stalled at $2.38, followed by sideways action that has completed a small-scale cup and handle breakout pattern. A buying spike over $2.60 can be expected to set the upside into action, supporting a rally that could surpass $5.00.

The company declared a cash dividend of $0.50 per share on its 8.00% Series B, Series C and Series D Cumulative Redeemable Perpetual Preferred Shares for the period from April 30, 2017 to July 29, 2017.

This is the 16th consecutive cash dividend declared on the company’s Series B Preferred Shares, the 13th cash dividend declared on its Series C Preferred Shares and the 12th cash dividend declared on its Series D Preferred Shares since their respective commencement of trading on the New York Stock Exchange.

10. Ballard Power Systems, Inc. (BLDP)

Source: Investopedia

Ballard Power Systems, Inc. (BLDP) is a provider of clean energy products that reduce customer costs and risks, and helps customers solve challenges in their fuel cell programs. The stock reached an all-time high at $144.95 in 2000 before falling into a downtrend lasting more than 12 years, sending the stock to an all-time low at 56 cents. A 2013 upward trend continued through 2014, hitting an 8-year high at $8.38, followed by a correction that’s now returned to 2015 resistance at $3.10. A breakout could catch fire, pushing the stock to a test of its 2014 high.

Total revenue was $22.7 million in the quarter, an increase of 39% from growth in both power products and technology solutions.

Gross margin was 42% in the quarter, an improvement of 22 points due to a shift in product mix toward higher margin technology solutions and heavy duty motive for the China market, including the establishment of a production line in Yunfu, China for the manufacture and assembly of FCvelocity-9SSL fuel cell stacks.

Cash operating costs were $10 million in the quarter, a 6% increase due to higher research and product development expenditures as well as a stronger Canadian dollar relative to the U.S. dollar, since a significant amount of cost is denominated in Canadian dollars.

Low-priced biotech stocks have risen following a long slumber, with steady buying interest likely to continue. This group should offer a variety of profitable penny stock plays during the quiet summer trading season, while low-priced stocks in other sectors move into narrow trading ranges.

Featured image from Shutterstock.

Important: Never invest money you can't afford to lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here.



Feedback or Requests?

Continue Reading

Autonomous

Drones Are a Next-Generation Computing Platform, Says Intel

Published

on

Intel drone

Intel announced the first Intel drone designed specifically for light shows: the Intel Shooting Star drone. With this drone, the company plans to demonstrate that drone light shows can redefine entertainment and create amazing new experiences in the night sky.

// -- Discuss and ask questions in our community on Workplace. Don't have an account? Send Jonas Borchgrevink an email -- //

(more…)

Important: Never invest money you can't afford to lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here.



Feedback or Requests?

Continue Reading

Electronics

Chinese Physicists Achieve Record-Breaking Quantum Cryptography Breakthrough

Published

on

Researchers at the University of Science and Technology of China and other Chinese labs, with the collaboration of a lab in the US, have implemented a secure quantum protocol known as Measurement-Device-Independent Quantum Key Distribution (MDIQKD), suitable for practical networks and devices, over a distance of 404 km. The breakthrough, which doubles the previous MDIQKD record, opens the door to secure wide area quantum communication networks.

// -- Discuss and ask questions in our community on Workplace. Don't have an account? Send Jonas Borchgrevink an email -- //

(more…)

Important: Never invest money you can't afford to lose. Always do your own research and due diligence before placing a trade. Read our Terms & Conditions here.



Feedback or Requests?

Continue Reading

Trending